Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
Front Pharmacol
.
2022 Nov 10:13:1067022.
doi: 10.3389/fphar.2022.1067022.
eCollection 2022.
Authors
Abdeslam Jaafari
1
2
,
Subramani Srinivasan
3
4
,
Mounir Tilaoui
5
Affiliations
1
Laboratory of Biological Engeneering, Sultan Moulay Slimane University, Beni Mellal, Morocco.
2
Lab of Bioprocess-Biointerfaces, Sultan Moulay Slimane University, Beni Mellal, Morocco.
3
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Chidambaram, Tamilnadu, India.
4
Postgraduate and Research Department of Biochemistry, Government Arts College for Women, Krishnagiri, Tamilnadu, India.
5
Pharmaceutical and Molecular Biotechnology Research Center, Waterford Institute of Technology, Waterford, Ireland.
PMID:
36438848
PMCID:
PMC9686424
DOI:
10.3389/fphar.2022.1067022
No abstract available
Keywords:
bioinformatics; cancer; data analysis; epigenetics; pharmacogenomics.
Publication types
Editorial